{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T17:29:31Z","timestamp":1788715771003,"version":"build-2803163510"},"reference-count":112,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism Reviews"],"published-print":{"date-parts":[[2024,4,2]]},"DOI":"10.1080\/03602532.2024.2326415","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T06:36:56Z","timestamp":1709707016000},"page":"127-144","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Favipiravir, remdesivir, and lopinavir: metabolites, degradation products and their analytical methods"],"prefix":"10.1080","volume":"56","author":[{"given":"Mir Saleh","family":"Hoseininezhad-Namin","sequence":"first","affiliation":[{"name":"Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences","place":["Tabriz, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Rahimpour","sequence":"additional","affiliation":[{"name":"Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences","place":["Tabriz, Iran"]},{"name":"Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences","place":["Tabriz, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolghasem","family":"Jouyban","sequence":"additional","affiliation":[{"name":"Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences","place":["Tabriz, Iran"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11696-022-02327-5"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scp.2022.100744"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mjafi.2020.08.004"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11224-020-01586-w"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2021.103385"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.10.006"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2022.2162967"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0612"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjac.2022.100063"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.47750\/pnr.2022.13.S07.928"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/9781439801802"},{"issue":"3","key":"e_1_3_2_13_1","first-page":"129","article-title":"Stability testing of pharmaceutical products","volume":"2","author":"Bajaj S","year":"2012","unstructured":"Bajaj S, Singla D, Sakhuja N. 2012. Stability testing of pharmaceutical products. J Appl Pharmaceut Sci. 2(3):129\u2013138.","journal-title":"J Appl Pharmaceut Sci"},{"key":"e_1_3_2_14_1","doi-asserted-by":"crossref","unstructured":"Brittain H.G. 2002. Profiles of drug substances excipients and related methodology. Anal Profiles Drug Subst Excipents 29 1\u20135.","DOI":"10.1016\/S0099-5428(08)60725-X"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0731-7085(02)00047-x"},{"issue":"14","key":"e_1_3_2_16_1","first-page":"1444","article-title":"Stability\u2010indicating RP HPLC method development for estimation of favipiravir in bulk and pharmaceutical dosage form","volume":"10","author":"Balu PA","year":"2021","unstructured":"Balu PA, Paresh MS. 2021. Stability\u2010indicating RP HPLC method development for estimation of favipiravir in bulk and pharmaceutical dosage form. World J Pharm Res. 10(14):1444\u20131465.","journal-title":"World J Pharm Res"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02346-12"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-2061-7074"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.52711\/2349-2988.2022.00041"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v10i2-s.4040"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-021-16096-3"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.12.020"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2013.09.003"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77700-z"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/16583655.2021.1991737"},{"key":"e_1_3_2_26_1","first-page":"57","volume-title":"Iran J Pharmaceutical Res IJPR","author":"Bulduk \u0130.","year":"2021","unstructured":"Bulduk \u0130. 2021. Comparison of HPLC and UV spectrophotometric methods for quantification of favipiravir in pharmaceutical formulations. Iran J Pharmaceutical Res IJPR. 20(3):57."},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1556\/1326.2020.00828"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.13005\/bbra\/3039"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2008.09.015"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104786"},{"key":"e_1_3_2_31_1","first-page":"1434","volume-title":"Infectious diseases","author":"Christine JK","unstructured":"Christine JK, Hammer SM. n.d. Chapter 145 - Antiretroviral agents. In: Infectious diseases. 3rd ed., Vol. 2, p. 1434\u20131453. Mosby, USA: Elsevier.","edition":"3"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A363"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408347.2022.2039094"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1039\/D1NJ00160D"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14070655"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.03.003"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1365\/s10337-006-0785-y"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1844"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.0c00489"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7020-6285-8.00152-0"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2006.11.037"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11224-020-01723-5"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1039\/d1ay00469g"},{"issue":"4","key":"e_1_3_2_44_1","first-page":"1950","article-title":"Overview of favipiravir and remdesivir treatment for COVID-19","volume":"12","author":"Eroglu E","year":"2021","unstructured":"Eroglu E, Toprak C. 2021. Overview of favipiravir and remdesivir treatment for COVID-19. Int J Pharm Sci Res. 12(4):1950\u20131957.","journal-title":"Int J Pharm Sci Res"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.09.015"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.93.027"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1021\/js950034i"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112324"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.013679"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2022.115165"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scp.2023.101093"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2022.123363"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108867"},{"key":"e_1_3_2_54_1","first-page":"1","article-title":"Stability testing of new drug substances and products","volume":"4","author":"Guideline I.","year":"2003","unstructured":"Guideline I. 2003. Stability testing of new drug substances and products. Q1A (R2), Current Step. 4:1\u201324. (","journal-title":"Q1A (R2), Current Step"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15227"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5212"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00890"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2013.07.013"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2223-y"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068347"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2429"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.10.069"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1080\/13102818.2020.1843539"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1177\/20587384211002621"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1039\/d3ra00654a"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1590\/S1984-82502014000200009"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1081\/ddc-100102246"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.32607\/actanaturae.11652"},{"issue":"1","key":"e_1_3_2_69_1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0090-9556(24)14888-X","article-title":"In vitro metabolism of the HIV-1 protease inhibitor ABT-378: species comparison and metabolite identification","volume":"27","author":"Kumar GN","year":"1999","unstructured":"Kumar GN, et\u00a0al. 1999. In vitro metabolism of the HIV-1 protease inhibitor ABT-378: species comparison and metabolite identification. Drug Metab Dispos. 27(1):86\u201391.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.111.041400"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2020.02.002"},{"issue":"3","key":"e_1_3_2_72_1","first-page":"391","article-title":"The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects","volume":"76","author":"Lynch T","year":"2007","unstructured":"Lynch T, Neff AP. 2007. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. American Family Physician. 76(3):391\u2013396.","journal-title":"American Family Physician"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0364-1"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.02.012"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2023.109815"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2021.106917"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2020.119241"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.671263"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072050"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2021.106189"},{"issue":"7","key":"e_1_3_2_81_1","first-page":"2317","article-title":"Development of UV spectrophotometric first order derivative method for the simultaneous estimation of ritonavir and lopinavir in combined tablet dosage form","volume":"3","author":"Nagulwar V","year":"2012","unstructured":"Nagulwar V, Bhusari K. 2012. Development of UV spectrophotometric first order derivative method for the simultaneous estimation of ritonavir and lopinavir in combined tablet dosage form. Int J Pharm Sci Res. 3(7):2317.","journal-title":"Int J Pharm Sci Res"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2021946118"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.112700"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13154"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2021.107101"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.0c00160"},{"issue":"3","key":"e_1_3_2_87_1","first-page":"17","article-title":"Stability indicating RP-HPLC method for determination of remdesivir in sublingual tablet dosage form","volume":"5","year":"2022","unstructured":"Padhye H, Sonawane B, Munipalli VK, Paranjpe AS, Singh RM, Nayak S, Bhaskar V, 2022. Stability indicating RP-HPLC method for determination of remdesivir in sublingual tablet dosage form. Inter Res J Pharm Med Sci. 5(3):17\u201323.","journal-title":"Inter Res J Pharm Med Sci"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.procbio.2020.12.014"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2021.03.015"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S332458"},{"key":"e_1_3_2_91_1","first-page":"1","volume-title":"J Electric Mach Control","author":"Reethu Sree C","year":"2023","unstructured":"Reethu Sree C, Babu B, Keerthivasan B, Vinay B, Balaji R, Gowtham GP, Ramesh J. 2023. Stability indicating analytical method of favipiravir API-identification and characterization of its degradant by forced degradation studies using LC-MS. J Electric Mach Control. 16(3):1\u20139."},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5098"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2022.06.004"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.04.234"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2023.115375"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.810"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.15.098731"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18463-z"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27072330"},{"key":"e_1_3_2_100_1","first-page":"271","volume-title":"J Taibah Univ Med Sci","author":"Shivanand NHB","year":"2015","unstructured":"Shivanand NHB, Charushila H. 2015. Development and validation of a stability indicating HPLC method for the simultaneous analysis of lopinavir and ritonavir in fixed-dose combination tablets. J Taibah Univ Med Sci. 10(3):271\u2013277."},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-020-01412-z"},{"key":"e_1_3_2_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-020-03263-6"},{"key":"e_1_3_2_103_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp274"},{"issue":"2","key":"e_1_3_2_104_1","first-page":"1","article-title":"UV spectrophotometric method development and validation of lopinavir in bulk and in pharmaceutical dosage form","volume":"6","author":"Sunkara N","year":"2017","unstructured":"Sunkara N, Vijayalakshmi A. 2017. UV spectrophotometric method development and validation of lopinavir in bulk and in pharmaceutical dosage form. CIBTech J Pharma Sci. 6(2):1\u20134.","journal-title":"CIBTech J Pharma Sci"},{"issue":"3","key":"e_1_3_2_105_1","first-page":"22","article-title":"A first-derivative spectrophotometric method for the estimation of Lopinavir in tablets. p","volume":"1","author":"Thakkar H","year":"2010","unstructured":"Thakkar H, Patel K. 2010. A first-derivative spectrophotometric method for the estimation of Lopinavir in tablets. p. Chron Young Scient. 1(3):22\u201322.","journal-title":"Chron Young Scient"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2022.10.026"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.1c03082"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408347.2021.1920364"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5363"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2021.114118"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.30574\/ijsra.2023.9.1.0424"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12815"},{"issue":"2","key":"e_1_3_2_113_1","first-page":"279","article-title":"LC-MS\/MS method for simultaneous quantification of lopinavir and ritonavir in human plasma","volume":"45","author":"Yao Y","year":"2010","unstructured":"Yao Y, et\u00a0al. 2010. LC-MS\/MS method for simultaneous quantification of lopinavir and ritonavir in human plasma. Yao Xue Xue Bao\u2009=\u2009Acta Pharmaceutica Sinica. 45(2):279\u2013282.","journal-title":"Yao Xue Xue Bao\u2009=\u2009Acta Pharmaceutica Sinica"}],"container-title":["Drug Metabolism Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03602532.2024.2326415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T13:40:07Z","timestamp":1753882807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03602532.2024.2326415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4,2]]}},"alternative-id":["10.1080\/03602532.2024.2326415"],"URL":"https:\/\/doi.org\/10.1080\/03602532.2024.2326415","relation":{},"ISSN":["0360-2532","1097-9883"],"issn-type":[{"value":"0360-2532","type":"print"},{"value":"1097-9883","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idmr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idmr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}